These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36802946)

  • 1. Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis.
    Qi W; Liu J; Li A
    Clin Appl Thromb Hemost; 2023; 29():10760296231157766. PubMed ID: 36802946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.
    Umemura Y; Yamakawa K; Ogura H; Yuhara H; Fujimi S
    J Thromb Haemost; 2016 Mar; 14(3):518-30. PubMed ID: 26670422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
    Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
    J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
    Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
    Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study.
    Kudo D; Hayakawa M; Iijima H; Yamakawa K; Saito S; Uchino S; Iizuka Y; Sanui M; Takimoto K; Mayumi T;
    Clin Appl Thromb Hemost; 2019; 25():1076029619839154. PubMed ID: 30919654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery.
    Hashimoto D; Okawa T; Maruyama R; Matsumura F; Shibata Y; Kohrogi H
    Anticancer Res; 2019 Jan; 39(1):25-31. PubMed ID: 30591437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study.
    Kudo D; Hayakawa M; Ono K; Yamakawa K
    Thromb Res; 2018 Mar; 163():22-29. PubMed ID: 29329022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation.
    Yamakawa K; Umemura Y; Murao S; Hayakawa M; Fujimi S
    Clin Appl Thromb Hemost; 2019; 25():1076029619835055. PubMed ID: 30841721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
    Yamakawa K; Gando S; Ogura H; Umemura Y; Kabata D; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
    Thromb Haemost; 2019 Nov; 119(11):1740-1751. PubMed ID: 31408900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Mediating Role of Multiple Organ Dysfunction in Sepsis-Induced Disseminated Intravascular Coagulation and Its Impact on Worsening Prognosis.
    Wang G; Hao C; Yao S; Wang Y; Xu Z; Zhao H; An Y
    Clin Appl Thromb Hemost; 2024; 30():10760296241271358. PubMed ID: 39109998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.
    Iba T; Gando S; Thachil J
    J Thromb Haemost; 2014 Jul; 12(7):1010-9. PubMed ID: 24801203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
    Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
    J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.
    Wang D; Yang Y; Wang Y; Proulle V; Andreasen PA; Hong W; Chen Z; Huang M; Xu P
    Biomed Pharmacother; 2020 Oct; 130():110528. PubMed ID: 32702634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
    Iba T; Nagaoka I; Boulat M
    Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation.
    Iba T; Helms J; Totoki T; Levy JH
    Semin Thromb Hemost; 2024 Oct; 50(7):1012-1018. PubMed ID: 38733977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
    Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
    Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
    Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.